SCHEMBL6806744

SCHEMBL6806744

COC1(OC)c2ccccc2C(=O)C12Cc1ccccc1C2

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPIB P23284 1/20 0.37
ALDH1A1 P00352 3/20 0.36
HSP90AA1 P07900 1/20 0.36
HSP90AB1 P08238 1/20 0.36
CYP2D6 P10635 2/20 0.35
L3MBTL1 Q9Y468 3/20 0.35
POLB P06746 2/20 0.35
NPSR1 Q6W5P4 2/20 0.34
LMNA P02545 2/20 0.34
HTT P42858 1/20 0.34
MAPT P10636 2/20 0.33
HTR2A P28223 2/20 0.33
HTR2C P28335 2/20 0.33
HTR2B P41595 2/20 0.33
SIGMAR1 Q99720 1/20 0.33
ITGA4 P13612 1/20 0.33
S100A4 P26447 1/20 0.33
CES1 P23141 1/20 0.32
MAOA P21397 1/20 0.32
KDM4E B2RXH2 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6806743 0.89 L3MBTL1 (0.40) PPIBALDH1A1CYP2D6L3MBTL1POLB
SCHEMBL6796515 0.75 ALDH1A1 (0.56) ALDH1A1HSP90AA1HSP90AB1CYP2D6L3MBTL1
SCHEMBL30349347 0.74 ALDH1A1 (0.41) ALDH1A1HSP90AA1HSP90AB1CYP2D6L3MBTL1
SCHEMBL132952 0.74 ALDH1A1 (0.41) ALDH1A1HSP90AA1HSP90AB1CYP2D6L3MBTL1
SCHEMBL132951 0.74 ALDH1A1 (0.41) ALDH1A1HSP90AA1HSP90AB1CYP2D6L3MBTL1
SCHEMBL31096283 0.73 ALDH1A1 (0.44) ALDH1A1HSP90AA1HSP90AB1CYP2D6L3MBTL1
SCHEMBL6801274 0.69 L3MBTL1 (0.44) PPIBALDH1A1L3MBTL1POLBNPSR1
SCHEMBL1793005 0.67 L3MBTL1 (0.46) PPIBALDH1A1CYP2D6L3MBTL1POLB
SCHEMBL29498104 0.67 L3MBTL1 (0.46) PPIBALDH1A1CYP2D6L3MBTL1POLB
SCHEMBL6796508 0.67 ALDH1A1 (0.46) ALDH1A1HSP90AA1HSP90AB1CYP2D6L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040082642-A1 Novel estrogen receptor ligands and method III MERCK & CO., INC. 2004-04-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040082642-A1 Novel estrogen receptor ligands and method III ESRRA, ESRRB, FSHR PPIB 1888/4885ALDH1A1 1752/4885HSP90AA1 2081/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.